Effects of Ramadan Intermittent Fasting on the Severity of ?-Thalassemia Major Patients

被引:0
作者
Ibraheem, Anas [1 ]
机构
[1] Imamein Kadhimein Med City, Internal Med, Baghdad, Iraq
关键词
medicine; hereditary disorder; baghdad; intermittent fasting; packed red blood cell transfusion; thalassemia & hemoglobinopathies; liver function; clinical hematology; ramadan fasting; 13-thalassemia major; PREVALENCE; SYSTEM;
D O I
10.7759/cureus.36735
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: 13-thalassemia major (13-TM) is an inherited autosomal recessive disorder manifested by the hemoglobin 13 chain synthesis alteration. It is a lifelong illness with a scope of a wide range of complications. Many kinds of literature evaluated the effect of Ramadan intermittent fasting (RIF) on different medical conditions. However, there are no precise guidelines regarding its effect on patients with 13-TM.Methods: A retrospective cohort study was conducted on 13-TM patients who visited the hereditary blood disorder center at Al Karama Teaching Hospital in Baghdad. Accordingly, six parameters were used to evaluate the effect of RIF on 13-TM patients before, during, and after Ramadan. These parameters include hemoglobin level, frequency of transfusion, aspartate aminotransferase (AST) level, alanine aminotransferase (ALT) level, left ventricular ejection fraction % (EF%), and spleen size. All of these details, including the demographic characteristics of age, gender, history of splenectomy, and body mass index (BMI) were retrieved from the patient's medical records after confirming their fasting through one-to-one interviews. This study aimed to fill the gap and investigate the possible effect of RIF on the severity of 13 -TM.Results: A total of 184 13-TM patients were enrolled in this study. The mean duration of fasting was 25.2 +/- 2.18 days. More than half (110) of the patients were females (59.8%). Whereas, the mean age was 24.8 +/- 3.5 years. One-third of the patients (65) had a splenectomy (35.3%) and more than two-thirds had normal BMI. The initial parameters used to score the severity of 13-TM were evaluated separately. As a result, the hemoglobin level remained steady without any statistical significance during the three months. In addition, the frequency of blood transfusion and the spleen size carried the same result. Although the lowest median and range of liver enzymes were recorded during Ramadan, they were statistically insignificant compared to pre and post-fasting. Moreover, the left ventricular EF% was insignificant regardless of the patient's history of heart disease.Conclusion: This study revealed that RIF does not seem to affect the severity of 13-TM if the patients proceed with fasting. However, further studies in more countries with a bigger sample size are recommended to confirm these findings.
引用
收藏
页数:7
相关论文
共 47 条
  • [1] Effects of Ramadan fasting on the symptoms of chronic heart failure
    Abazid, Rami M.
    Khalaf, Hassan H.
    Sakr, Haitham L.
    Altorbak, Nora A.
    Alenzi, Habiba S.
    Awad, Zaki M.
    Smettei, Osama A.
    Elsanan, Moataz A.
    Widyan, Adel M.
    Azazy, Ahmed S.
    Chamsi-Pasha, Hassan W.
    [J]. SAUDI MEDICAL JOURNAL, 2018, 39 (04) : 394 - 399
  • [2] Effects of Intermittent Fasting on Patients with Sickle Cell Disease Single Center Experience
    Ahmed, Khalid
    Abdu, Yasamin
    Khasawneh, Sief
    Shukri, Ahmed
    Adam, Ehab
    Mustafa, Salma
    Affas, Mohammad
    Yassin, Mohamed A.
    [J]. BLOOD, 2022, 140 : 11131 - 11132
  • [3] Al Hourani HM, 2009, Jordan Journal of Biological Sciences, V2, P103
  • [4] Prevalence of β-thalassemia trait in premarital screening in Al-Hassa, Saudi Arabia
    Al-Suliman, A
    [J]. ANNALS OF SAUDI MEDICINE, 2006, 26 (01) : 14 - 16
  • [5] Clinical outcomes of fasting in patients with chronic heart failure with preserved ejection fraction: A prospective analysis
    Alam, Shafiq
    Hussain, Shoukat
    Abbas, Jawad
    Raza, Muhammad Hassan
    Rasool, Waqar Arif
    Alsubai, Abdulla K.
    Al-Mousawi, Razan
    Aldhaheri, Khaled Saeed Obaid
    Malik, Jahanzeb
    Almas, Talal
    [J]. ANNALS OF MEDICINE AND SURGERY, 2022, 81
  • [6] Current status of beta-thalassemia and its treatment strategies
    Ali, Shaukat
    Mumtaz, Shumaila
    Shakir, Hafiz Abdullah
    Khan, Muhammad
    Tahir, Hafiz Muhammad
    Mumtaz, Samaira
    Mughal, Tafail Akbar
    Hassan, Ali
    Kazmi, Syed Akif Raza
    Sadia
    Irfan, Muhammad
    Khan, Muhammad Adeeb
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (12):
  • [7] AlQahtani R., 2018, Journal of Applied Hematology, V9, P59, DOI [DOI 10.4103/JOAH.JOAH_1_18, 10.4103/joah.joah118, DOI 10.4103/JOAH.JOAH118]
  • [8] [Anonymous], 2021, INT FAST MAY PROT HE
  • [9] Azizi F., 1987, Medical Journal of The Islamic Republic of Iran (MJIRI), V1, P38
  • [10] Bajwa H, 2022, Thalassemia